NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time

Rhea-AI Summary

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC), a medical technology company specializing in neurological disorder treatments, will announce its fiscal second quarter 2025 financial results on May 13, 2025, before market open. The company will host an investor conference call and webcast at 8:30 a.m. Eastern time the same day.

Management will discuss Q2 financial results, provide corporate updates, and hold a Q&A session. The conference call can be accessed via U.S. toll-free number (888-506-0062) or international number (973-528-0011) using participant code 655933. A playback will be available until May 27, 2025, through domestic (877-481-4010) and international (919-882-2331) numbers with replay passcode 52404.

EDEN PRAIRIE, Minn., May 01, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal second quarter ended March 31, 2025, before market open on May 13, 2025.

Management will host an investor conference call and webcast at 8:30 a.m. Eastern time on Tuesday, May 13, 2025, to discuss the Company’s second quarter fiscal year 2025 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:

Second Quarter 2025 Earnings Conference Call
Date: Tuesday, May 13, 2025
Time: 8:30 a.m. Eastern time
U.S. Dial-In (Toll Free): 888-506-0062
International Dial-In: 973-528-0011
Participant Access Code: 655933
Webcast: 2Q25 Webcast Link

Please join at least five minutes before the start of the call to ensure timely participation.

A playback of the call will be available through Tuesday, May 27, 2025. To listen, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 52404. A webcast replay will also be available using the webcast link above through May 27, 2025.

About NeuroOne

NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.

IR Contact
MZ Group – MZ North America
NMTC@mzgroup.us

FAQ

When will NeuroOne (NMTC) report its Q2 2025 earnings?

NeuroOne will report its Q2 2025 earnings on Tuesday, May 13, 2025, before market open, with a conference call scheduled for 8:30 a.m. Eastern time.

How can investors access NMTC's Q2 2025 earnings call?

Investors can access the call using U.S. toll-free number 888-506-0062 or international number 973-528-0011 with participant code 655933. A webcast will also be available.

Until when will the replay of NeuroOne's Q2 2025 earnings call be available?

The earnings call replay will be available through Tuesday, May 27, 2025, via phone (877-481-4010 US, 919-882-2331 international) using passcode 52404 or through the webcast link.

What period does NeuroOne's Q2 2025 earnings report cover?

The earnings report covers NeuroOne's fiscal second quarter ended March 31, 2025.